Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Good results reported for deferasirox in transfusion-related iron overload

June 27, 2005

Priority review for Exjade

June 23, 2005

Antagonism of D3 receptors attenuates ethanol consumption in rats / News in Context

June 20, 2005

Rimonabant under clinical evaluation for maintaining smoking cessation

June 6, 2005

Neumune IND filed in U.S.

June 1, 2005

Vivitrex NDA accepted for priority review

May 31, 2005

AN-53 exerts antiopiate activity in vitro and in vivo

May 26, 2005

Novartis files oral iron chelator Exjade in U.S., Europe

May 4, 2005

Prodrugs for treating alcoholism and opioid dependency developed at the University of Kentucky

April 26, 2005

New antismoking therapy developed by Pfizer

April 20, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...